JPWO2022051582A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022051582A5 JPWO2022051582A5 JP2023514910A JP2023514910A JPWO2022051582A5 JP WO2022051582 A5 JPWO2022051582 A5 JP WO2022051582A5 JP 2023514910 A JP2023514910 A JP 2023514910A JP 2023514910 A JP2023514910 A JP 2023514910A JP WO2022051582 A5 JPWO2022051582 A5 JP WO2022051582A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- disorder
- compound
- optionally
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| US63/074,521 | 2020-09-04 | ||
| PCT/US2021/049001 WO2022051582A1 (en) | 2020-09-04 | 2021-09-03 | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540733A JP2023540733A (ja) | 2023-09-26 |
| JPWO2022051582A5 true JPWO2022051582A5 (https=) | 2024-09-09 |
| JP2023540733A5 JP2023540733A5 (https=) | 2024-09-09 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514910A Pending JP2023540733A (ja) | 2020-09-04 | 2021-09-03 | アルキルオキサシクロアルキル部分を含むスルファモイル尿素誘導体およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (https=) |
| EP (1) | EP4208459A1 (https=) |
| JP (1) | JP2023540733A (https=) |
| KR (1) | KR20230061505A (https=) |
| CN (1) | CN116783184A (https=) |
| AR (1) | AR123435A1 (https=) |
| AU (1) | AU2021336518A1 (https=) |
| BR (1) | BR112023003792A2 (https=) |
| CA (1) | CA3191410A1 (https=) |
| IL (1) | IL301055A (https=) |
| MX (1) | MX2023002686A (https=) |
| WO (1) | WO2022051582A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| PL3983387T3 (pl) | 2019-06-12 | 2024-08-19 | NodThera Limited | Pochodne sulfonylomocznika i ich zastosowania |
| WO2025104268A1 (en) | 2023-11-17 | 2025-05-22 | NodThera Limited | Forms of urea derivatives and related uses |
| WO2025104244A1 (en) * | 2023-11-17 | 2025-05-22 | NodThera Limited | Methods of preparing urea derivatives |
| WO2025153532A1 (en) * | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| PT1270565E (pt) | 1997-01-29 | 2004-09-30 | Pfizer | Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia |
| SI3259253T1 (sl) * | 2015-02-16 | 2020-07-31 | The University Of Queensland | Sulfonilsečnine in sorodne spojine ter njihova uporaba |
| ES2988798T3 (es) | 2017-07-24 | 2024-11-21 | Novartis Ag | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| KR20210053910A (ko) * | 2018-08-15 | 2021-05-12 | 인플라좀 리미티드 | 신규한 설폰아마이드유레아 화합물 |
-
2021
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 JP JP2023514910A patent/JP2023540733A/ja active Pending
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
- 2021-09-03 AU AU2021336518A patent/AU2021336518A1/en active Pending
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116568688B (zh) | 用于治疗病毒感染的化合物和方法 | |
| JP6409001B2 (ja) | Ｈｂｖ感染に対する新規抗ウイルス剤 | |
| EA020749B1 (ru) | Вич-ингибирующие 5,6-замещенные пиримидины | |
| CN121800834A (zh) | 1’-氰基核苷类似物及其用途 | |
| JP2020528889A5 (https=) | ||
| JP2022541404A (ja) | インフルエンザウイルス感染症の治療に有用な化合物 | |
| JP2025524640A (ja) | Ｎｌｒｐ３インフラマソーム経路の調節剤としてのピロロトリアジン及びイミダゾトリアジン誘導体 | |
| JP2018531289A5 (https=) | ||
| US20250304560A1 (en) | Modulators of nlrp3 inflammasome and related products and methods | |
| KR20230021083A (ko) | 면역 조절제 | |
| AU2021300192A1 (en) | Compounds, compositions and methods | |
| AU2022366992A1 (en) | Integrin inhibitors and uses thereof in combination with other agents | |
| JPWO2022051582A5 (https=) | ||
| US20240254132A1 (en) | Compounds, compositions and methods | |
| JPWO2020102576A5 (https=) | ||
| HRP20240896T1 (hr) | Derivati sulfoniluree i njihova upotreba | |
| CN110483417B (zh) | 一种DACOs类NNRTIs氨基酸酯衍生物、其制备方法、药物组合物及应用 | |
| CN111777638B (zh) | 喹啉类化合物、其制备方法、药物组合物和用途 | |
| RU2023108168A (ru) | Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения | |
| WO2023211940A1 (en) | Sting agonists, formulations, and uses thereof | |
| JPWO2020249664A5 (https=) | ||
| JPWO2023133271A5 (https=) | ||
| US20240391932A1 (en) | Compounds, compositions and methods | |
| CN113082023B (zh) | P2x3抑制剂和p2x4抑制剂的药物组合及其应用 | |
| JPWO2020249667A5 (https=) |